Insider Transactions in Q3 2025 at Royalty Pharma PLC (RPRX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 11
2025
|
Gregory Norden Director |
SELL
Open market or private sale
|
Direct |
33,500
-14.67%
|
$1,206,000
$36.23 P/Share
|
|
Aug 08
2025
|
Gregory Norden Director |
BUY
Conversion of derivative security
|
Direct |
144,660
+38.78%
|
-
|
|
Aug 06
2025
|
Legorreta Pablo G. CEO, Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
21,901
+2.36%
|
-
|
|
Aug 06
2025
|
Christopher Hite EVP & Vice Chairman |
BUY
Grant, award, or other acquisition
|
Indirect |
3,696
+0.56%
|
-
|
|
Aug 06
2025
|
George W. Lloyd EVP, Investments & CLO |
BUY
Grant, award, or other acquisition
|
Indirect |
3,696
+6.6%
|
-
|
|
Aug 06
2025
|
Terrance P. Coyne EVP & CFO |
BUY
Grant, award, or other acquisition
|
Indirect |
3,696
+6.6%
|
-
|
|
Aug 06
2025
|
Marshall Urist EVP, Research & Investments |
BUY
Grant, award, or other acquisition
|
Direct |
2,772
+6.6%
|
-
|
|
Jul 31
2025
|
Elizabeth H Weatherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,558
+45.21%
|
-
|
|
Jul 31
2025
|
Carole Ho Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,558
+45.21%
|
-
|